988 related articles for article (PubMed ID: 31122494)
1. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
Toyoda K; Uchiyama S; Yamaguchi T; Easton JD; Kimura K; Hoshino H; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K;
Lancet Neurol; 2019 Jun; 18(6):539-548. PubMed ID: 31122494
[TBL] [Abstract][Full Text] [Related]
2. Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial.
Hoshino H; Toyoda K; Omae K; Ishida N; Uchiyama S; Kimura K; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T;
Stroke; 2021 Nov; 52(11):3430-3439. PubMed ID: 34404237
[TBL] [Abstract][Full Text] [Related]
3. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T;
Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817
[TBL] [Abstract][Full Text] [Related]
4. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
[TBL] [Abstract][Full Text] [Related]
5. Association of Timing for Starting Dual Antiplatelet Treatment With Cilostazol and Recurrent Stroke: A CSPS.com Trial Post Hoc Analysis.
Toyoda K; Omae K; Hoshino H; Uchiyama S; Kimura K; Miwa K; Minematsu K; Yamaguchi K; Suda Y; Toru S; Kitagawa K; Ihara M; Koga M; Yamaguchi T;
Neurology; 2022 Mar; 98(10):e983-e992. PubMed ID: 35074890
[TBL] [Abstract][Full Text] [Related]
6. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study.
Huang Y; Cheng Y; Wu J; Li Y; Xu E; Hong Z; Li Z; Zhang W; Ding M; Gao X; Fan D; Zeng J; Wong K; Lu C; Xiao J; Yao C;
Lancet Neurol; 2008 Jun; 7(6):494-9. PubMed ID: 18456558
[TBL] [Abstract][Full Text] [Related]
7. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial.
Wong KS; Chen C; Fu J; Chang HM; Suwanwela NC; Huang YN; Han Z; Tan KS; Ratanakorn D; Chollate P; Zhao Y; Koh A; Hao Q; Markus HS;
Lancet Neurol; 2010 May; 9(5):489-97. PubMed ID: 20335070
[TBL] [Abstract][Full Text] [Related]
8. Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial.
Nishiyama Y; Kimura K; Otsuka T; Toyoda K; Uchiyama S; Hoshino H; Sakai N; Okada Y; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T;
Stroke; 2023 Mar; 54(3):697-705. PubMed ID: 36734235
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS): a parallel, randomised, open-label, multicentre, prospective study.
Hou X; Li X; Wang X; Chen H
Stroke Vasc Neurol; 2018 Dec; 3(4):263-267. PubMed ID: 30637134
[TBL] [Abstract][Full Text] [Related]
11. Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I).
Ogawa A; Toyoda K; Kitagawa K; Kitazono T; Nagao T; Yamagami H; Uchiyama S; Tanahashi N; Matsumoto M; Minematsu K; Nagata I; Nishikawa M; Nanto S; Abe K; Ikeda Y;
Lancet Neurol; 2019 Mar; 18(3):238-247. PubMed ID: 30784555
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.
Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Duley L; England TJ; Flaherty K; Havard D; Heptinstall S; James M; Krishnan K; Markus HS; Montgomery AA; Pocock SJ; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N;
Lancet; 2018 Mar; 391(10123):850-859. PubMed ID: 29274727
[TBL] [Abstract][Full Text] [Related]
13. Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial.
Kim BJ; Lee EJ; Kwon SU; Park JH; Kim YJ; Hong KS; Wong LKS; Yu S; Hwang YH; Lee JS; Lee J; Rha JH; Heo SH; Ahn SH; Seo WK; Park JM; Lee JH; Kwon JH; Sohn SI; Jung JM; Navarro JC; Kang DW;
Lancet Neurol; 2018 Jun; 17(6):509-518. PubMed ID: 29778364
[TBL] [Abstract][Full Text] [Related]
14. Randomized Comparisons of Double-Dose Clopidogrel or Adjunctive Cilostazol Versus Standard Dual Antiplatelet in Patients With High Posttreatment Platelet Reactivity: Results of the CREATIVE Trial.
Tang YD; Wang W; Yang M; Zhang K; Chen J; Qiao S; Yan H; Wu Y; Huang X; Xu B; Gao R; Yang Y;
Circulation; 2018 May; 137(21):2231-2245. PubMed ID: 29420189
[TBL] [Abstract][Full Text] [Related]
15. Dual antiplatelet therapy with cilostazol in stroke patients with extracranial arterial stenosis or without arterial stenosis: A subgroup analysis of the CSPS.com trial.
Uchiyama S; Toyoda K; Okamura S; Omae K; Hoshino H; Kimura K; Kitagawa K; Minematsu K; Yamaguchi T
Int J Stroke; 2023 Apr; 18(4):426-432. PubMed ID: 35762581
[TBL] [Abstract][Full Text] [Related]
16. Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial.
Koo BK; Kang J; Park KW; Rhee TM; Yang HM; Won KB; Rha SW; Bae JW; Lee NH; Hur SH; Yoon J; Park TH; Kim BS; Lim SW; Cho YH; Jeon DW; Kim SH; Han JK; Shin ES; Kim HS;
Lancet; 2021 Jun; 397(10293):2487-2496. PubMed ID: 34010616
[TBL] [Abstract][Full Text] [Related]
17. Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis.
Hao Q; Tampi M; O'Donnell M; Foroutan F; Siemieniuk RA; Guyatt G
BMJ; 2018 Dec; 363():k5108. PubMed ID: 30563866
[TBL] [Abstract][Full Text] [Related]
18. Short- vs. long-term dual antiplatelet therapy in secondary prevention for ischaemic stroke: a network metanalysis.
Pugliese F; Arasaratnam P; Moellenberg M; Dani S
Eur Heart J Qual Care Clin Outcomes; 2019 Oct; 5(4):298-309. PubMed ID: 31050716
[TBL] [Abstract][Full Text] [Related]
19. Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis.
Uchiyama S; Toyoda K; Omae K; Saita R; Kimura K; Hoshino H; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T
J Am Heart Assoc; 2021 Oct; 10(20):e022575. PubMed ID: 34622679
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Cilostazol versus Clopidogrel in Addition to Aspirin in Patients with Ischemic Stroke who Underwent Intracranial or Extracranial Artery Stent Implantation.
Liu H; Shao T; Yang T; Li D; Wang H; Cheng Y; Zhang T; Zhang J
J Atheroscler Thromb; 2023 Aug; 30(8):1010-1021. PubMed ID: 36328566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
